Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 172,401 | 183,774 | 177,235 | 121,747 | 174,282 |
| Cost of Goods | 69,076 | 85,687 | 66,867 | 30,190 | 65,794 |
| Gross Profit | 103,325 | 98,087 | 110,368 | 91,557 | 108,488 |
| Operating Expenses | 116,052 | 130,660 | 96,484 | 98,911 | 86,509 |
| Operating Income | -12,651 | -31,886 | 14,751 | -7,164 | 22,773 |
| Interest Expense | 3,958 | 3,892 | 3,860 | 4,388 | 3,765 |
| Other Income | -5,873 | 7,176 | 6,199 | 5,376 | 4,806 |
| Pre-tax Income | -22,482 | -28,602 | 17,090 | -6,176 | 23,814 |
| Income Tax | -5,693 | -23,428 | 22,095 | -14,890 | 16,068 |
| Net Income Continuous | -16,789 | -5,174 | -5,005 | 8,714 | 7,746 |
| Minority Interests | -53 | -17 | -9 | -112 | -47 |
| Net Income | $-16,736 | $-5,157 | $-4,996 | $1,198 | $7,793 |
| EPS Basic Total Ops | -0.26 | -0.08 | -0.08 | 0.02 | 0.13 |
| EPS Basic Continuous Ops | -0.26 | -0.08 | -0.08 | 0.16 | 0.13 |
| EPS Diluted Total Ops | -0.26 | -0.08 | -0.08 | 0.04 | 0.12 |
| EPS Diluted Continuous Ops | -0.26 | -0.08 | -0.08 | 0.16 | 0.12 |
| EBITDA(a) | $-625 | $-19,851 | $25,604 | $7,957 | $32,751 |